DK1664033T3 - 9,10-a,a-OH-taxan-analoger samt fremgangsmåder til fremstilling deraf. - Google Patents

9,10-a,a-OH-taxan-analoger samt fremgangsmåder til fremstilling deraf.

Info

Publication number
DK1664033T3
DK1664033T3 DK04789167T DK04789167T DK1664033T3 DK 1664033 T3 DK1664033 T3 DK 1664033T3 DK 04789167 T DK04789167 T DK 04789167T DK 04789167 T DK04789167 T DK 04789167T DK 1664033 T3 DK1664033 T3 DK 1664033T3
Authority
DK
Denmark
Prior art keywords
group
hydroxyl
methods
present
taxane
Prior art date
Application number
DK04789167T
Other languages
English (en)
Inventor
James D Mcchesney
James Ferrara
Jan Zygmut
Original Assignee
Tapestry Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1664033T3 publication Critical patent/DK1664033T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK04789167T 2003-09-25 2004-09-27 9,10-a,a-OH-taxan-analoger samt fremgangsmåder til fremstilling deraf. DK1664033T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25
PCT/US2004/031816 WO2005030150A2 (en) 2003-09-25 2004-09-27 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
DK1664033T3 true DK1664033T3 (da) 2008-03-25

Family

ID=34393186

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04789167T DK1664033T3 (da) 2003-09-25 2004-09-27 9,10-a,a-OH-taxan-analoger samt fremgangsmåder til fremstilling deraf.

Country Status (14)

Country Link
US (8) US7745650B2 (da)
EP (2) EP1664033B1 (da)
JP (5) JP4874102B2 (da)
CN (1) CN1886400A (da)
AT (1) ATE377593T1 (da)
AU (1) AU2004275881A1 (da)
CA (1) CA2539975C (da)
DE (1) DE602004009943T2 (da)
DK (1) DK1664033T3 (da)
ES (1) ES2295937T3 (da)
HR (1) HRP20080057T3 (da)
PL (1) PL1664033T3 (da)
PT (1) PT1664033E (da)
WO (1) WO2005030150A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20080057T3 (en) * 2003-09-25 2008-02-29 Tapestry Pharmaceuticals 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
WO2007086879A2 (en) 2005-02-11 2007-08-02 University Of Southern California Method of expressing proteins with disulfide bridges
MX2008008119A (es) * 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
JP2009521435A (ja) * 2005-12-21 2009-06-04 タペストリー ファーマシューティカルズ インコーポレーテッド タキサンを形成するための新規化合物および方法ならびにその使用
AU2007245085A1 (en) * 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
EP2029563A4 (en) * 2006-06-12 2009-12-02 Canada Inc 6570763 HALF-SYNTHETIC ROUTE FOR THE PREPARATION OF PACLITAXEL, DOCETAXEL AND 10-DEACETYLBACCATIN III FROM 9-DIHYDRO-13-ACETYLBACCATIN III
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
CN103764138A (zh) * 2011-04-07 2014-04-30 阿伯疗法责任有限公司 紫杉烷和Abeo-紫杉烷类似物
US8440714B2 (en) * 2011-06-06 2013-05-14 Arbor Therapeutics, LLC Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
US12403024B2 (en) 2020-03-04 2025-09-02 Aquedeon Medical, Inc. Vascular and aortic grafts with telescoping sheath and deployment methods thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) * 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
DE69325454T2 (de) * 1992-04-17 2000-01-20 Abbott Laboratories, Abbott Park Taxol-derivate
FR2697019B1 (fr) * 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
ES2206465T3 (es) 1992-11-13 2004-05-16 Florida State University Taxanos sustituidos con butenilo y composiciones farmaceuticas.
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
EP0687260B1 (en) * 1993-03-05 2003-02-19 Florida State University Process for the preparation of 9-desoxotaxanes
ATE218858T1 (de) 1993-03-05 2002-06-15 Univ Florida State C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen
JPH08508469A (ja) 1993-03-22 1996-09-10 フロリダ・ステート・ユニバーシティー アルコキシ、アルケンオキシまたはアリールオキシ置換側鎖を有するタキサンおよびそれを含有する薬剤組成物
FR2707293A1 (fr) 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
CN1362876A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10杂取代的乙酸基紫衫烷抗肿瘤剂
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
AU2002254400B2 (en) 2001-03-23 2007-08-09 Napro Biotherapeutics, Inc. Molecular conjugates for use in treatment of cancer
CA2354471A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
HRP20040545A2 (en) 2001-12-20 2005-08-31 Bristol-Myers Squibb Company A Delaware (Usa) Corp Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
EP1810968A3 (en) 2003-09-25 2007-08-08 Tapestry Pharmaceuticals, Inc. 9, 10-a, a-OH-taxane analogs and methods for production thereof
HRP20080057T3 (en) 2003-09-25 2008-02-29 Tapestry Pharmaceuticals 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
KR20080030564A (ko) 2005-05-12 2008-04-04 태피스트리 파마슈티컬스 인코퍼레이티드 표적 컨쥬게이트에 적합한 분자 구조물
JP2009521435A (ja) 2005-12-21 2009-06-04 タペストリー ファーマシューティカルズ インコーポレーテッド タキサンを形成するための新規化合物および方法ならびにその使用
MX2008008119A (es) 2005-12-21 2008-09-24 Tapestry Pharmaceuticals Inc Procesos para derivados de taxano y compuestos intermedios utiles en los mismos.
AU2007245085A1 (en) 2006-03-27 2007-11-08 Tapestry Pharmaceuticals, Inc. A convergent process for the synthesis of taxane derivatives
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Also Published As

Publication number Publication date
JP2007506792A (ja) 2007-03-22
DE602004009943T2 (de) 2008-08-28
DE602004009943D1 (de) 2007-12-20
US20200237708A1 (en) 2020-07-30
CN1886400A (zh) 2006-12-27
US9820962B2 (en) 2017-11-21
AU2004275881A1 (en) 2005-04-07
ATE377593T1 (de) 2007-11-15
EP1664033A2 (en) 2006-06-07
US10639293B2 (en) 2020-05-05
EP1664033A4 (en) 2006-09-13
JP5525394B2 (ja) 2014-06-18
JP2016180006A (ja) 2016-10-13
US20150133536A1 (en) 2015-05-14
US20050148657A1 (en) 2005-07-07
US20160331718A1 (en) 2016-11-17
US10238621B2 (en) 2019-03-26
US7745650B2 (en) 2010-06-29
EP1785416A2 (en) 2007-05-16
US9402824B2 (en) 2016-08-02
WO2005030150A2 (en) 2005-04-07
CA2539975A1 (en) 2005-04-07
JP6216417B2 (ja) 2017-10-18
JP2011012070A (ja) 2011-01-20
US20190142784A1 (en) 2019-05-16
JP5629632B2 (ja) 2014-11-26
JP2011137045A (ja) 2011-07-14
WO2005030150A3 (en) 2005-07-14
EP1664033B1 (en) 2007-11-07
JP4874102B2 (ja) 2012-02-15
PL1664033T3 (pl) 2008-04-30
EP1785416A3 (en) 2007-05-30
ES2295937T3 (es) 2008-04-16
PT1664033E (pt) 2008-01-17
US20120077871A1 (en) 2012-03-29
US7879904B2 (en) 2011-02-01
CA2539975C (en) 2012-11-20
JP2014196345A (ja) 2014-10-16
US8962870B2 (en) 2015-02-24
JP6106634B2 (ja) 2017-04-05
HRP20080057T3 (en) 2008-02-29
US20180125811A1 (en) 2018-05-10
US20100324128A1 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
DK1664033T3 (da) 9,10-a,a-OH-taxan-analoger samt fremgangsmåder til fremstilling deraf.
DK1628685T3 (da) Antivirale phosphonatanaloge
BRPI0413934A (pt) compostos orgánicos
BRPI0607817A2 (pt) processo para a preparação de compostos macrocìclicos
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
ATE556085T1 (de) Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna
DE60220422D1 (de) Substituierte pyrazoloverbindungen zur behandlung von entzündungen
EP2671581A3 (en) Compositions and methods for treating cancer
ATE543494T1 (de) Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung
DE69217873D1 (de) Verfahren zur Herstellung von 2-Chlor-2'-Desoxyadenosin
WO2009081152A3 (en) Antimicrobial compounds
DE50308114D1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen
PA8676301A1 (es) Metodos para sintetizar derivados de 6-alquilaminoquinolina
AR035419A1 (es) Un proceso para preparar compuestos imidazo-tetrazin-4-ona, compuestos intermediarios, sales de adicion de acidos, un proceso para preparar la temozolomida, un proceso para preparar intermediarios
WO2005089256A3 (en) Antiangiogenic agents
WO2003031499A3 (de) Photochemisch und/oder thermisch strukturierbare harze auf silanbasis, einstufiges verfahren zu deren herstellung, dabei einsetzbare ausgangsverbindungen und herstellungsverfahren für diese
WO2010002528A3 (en) Hydrofluoroacetal compounds and processes for their preparation and use
ATE536875T1 (de) Verfahren und zwischenzusammensetzungen zur herstellung von statinen, insbesondere rosuvastatin
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
EP1810968A3 (en) 9, 10-a, a-OH-taxane analogs and methods for production thereof
WO2014184272A3 (en) Chemical compositions for targeting isocitrate dehydrogenase and for treating cancer
BRPI0712192A2 (pt) Composição de poliolefina, mistura-padrão processo para produção de um artigo, artigo, uso de uma composição de poliolefina e uso de um composto contendo silício
DE602004014769D1 (de) Reaktive flammschutzmittel und flammgeschützte harzprodukte
PE20091359A1 (es) Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina
ATE325159T1 (de) Verfahren zur herstellung von synergistischen stabilisatorgemischen